{"entity_poly": {"nstd_linkage": "no", "nstd_monomer": "yes", "pdbx_seq_one_letter_code": "MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPV(CSO)PPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF", "pdbx_seq_one_letter_code_can": "MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF", "pdbx_strand_id": "A,B", "rcsb_artifact_monomer_count": 0, "rcsb_conflict_count": 0, "rcsb_deletion_count": 0, "rcsb_entity_polymer_type": "Protein", "rcsb_insertion_count": 0, "rcsb_mutation_count": 1, "rcsb_non_std_monomer_count": 1, "rcsb_non_std_monomers": ["CSO"], "rcsb_sample_sequence_length": 222, "type": "polypeptide(L)"}, "entity_src_gen": [{"gene_src_common_name": "human", "gene_src_genus": "Homo", "host_org_genus": "Escherichia", "pdbx_alt_source_flag": "sample", "pdbx_gene_src_ncbi_taxonomy_id": "9606", "pdbx_gene_src_scientific_name": "Homo sapiens", "pdbx_host_org_ncbi_taxonomy_id": "562", "pdbx_host_org_scientific_name": "Escherichia coli", "pdbx_host_org_vector_type": "plasmid", "pdbx_src_id": 1, "plasmid_name": "pGEM-3Zf(+)"}], "rcsb_cluster_flexibility": {"avg_rmsd": 0.556, "label": "Low", "link": "http://pdbflex.org/cluster.html#!/2wjuA/10133/1pkwA", "max_rmsd": 1.21, "provenance_code": "PDBFlex"}, "rcsb_cluster_membership": [{"cluster_id": 3739, "identity": 100}, {"cluster_id": 2079, "identity": 95}, {"cluster_id": 1870, "identity": 90}, {"cluster_id": 1518, "identity": 70}, {"cluster_id": 1653, "identity": 50}, {"cluster_id": 1012, "identity": 30}], "rcsb_entity_host_organism": [{"ncbi_common_names": ["Bacillus coli", "Bacterium coli", "Bacterium coli commune", "E. coli", "Enterococcus coli", "Escherichia/Shigella coli"], "ncbi_parent_scientific_name": "Bacteria", "ncbi_scientific_name": "Escherichia coli", "ncbi_taxonomy_id": 562, "pdbx_src_id": 1, "provenance_source": "Primary Data", "scientific_name": "Escherichia coli", "taxonomy_lineage": [{"depth": 1, "id": "131567", "name": "cellular organisms"}, {"depth": 1, "id": "131567", "name": "biota"}, {"depth": 2, "id": "2", "name": "Bacteria"}, {"depth": 2, "id": "2", "name": "Bacteria (ex Cavalier-Smith 1987)"}, {"depth": 2, "id": "2", "name": "Bacteria Woese et al. 2024"}, {"depth": 2, "id": "2", "name": "Bacteriobiota"}, {"depth": 2, "id": "2", "name": "bacteria"}, {"depth": 2, "id": "2", "name": "eubacteria"}, {"depth": 3, "id": "3379134", "name": "Pseudomonadati"}, {"depth": 4, "id": "1224", "name": "Pseudomonadota"}, {"depth": 4, "id": "1224", "name": "\"Alphaproteobacteriota\" Whitman et al. 2018"}, {"depth": 4, "id": "1224", "name": "Alphaproteobacteriota"}, {"depth": 4, "id": "1224", "name": "Proteobacteria"}, {"depth": 4, "id": "1224", "name": "Proteobacteriota"}, {"depth": 4, "id": "1224", "name": "proteobacteria"}, {"depth": 4, "id": "1224", "name": "purple photosynthetic bacteria and relatives"}, {"depth": 5, "id": "1236", "name": "Gammaproteobacteria"}, {"depth": 5, "id": "1236", "name": "Proteobacteria gamma subdivision"}, {"depth": 5, "id": "1236", "name": "Pseudomonadia"}, {"depth": 5, "id": "1236", "name": "Purple bacteria, gamma subdivision"}, {"depth": 5, "id": "1236", "name": "g-proteobacteria"}, {"depth": 5, "id": "1236", "name": "gamma proteobacteria"}, {"depth": 5, "id": "1236", "name": "gamma subdivision"}, {"depth": 5, "id": "1236", "name": "gamma subgroup"}, {"depth": 6, "id": "91347", "name": "Enterobacterales"}, {"depth": 6, "id": "91347", "name": "Enterobacteriaceae and related endosymbionts"}, {"depth": 6, "id": "91347", "name": "Enterobacteriaceae group"}, {"depth": 6, "id": "91347", "name": "Enterobacteriales"}, {"depth": 7, "id": "543", "name": "Enterobacteriaceae"}, {"depth": 7, "id": "543", "name": "Enterobacteraceae"}, {"depth": 7, "id": "543", "name": "enterobacteria"}, {"depth": 8, "id": "561", "name": "Escherichia"}, {"depth": 9, "id": "562", "name": "Escherichia coli"}, {"depth": 9, "id": "562", "name": "Bacillus coli"}, {"depth": 9, "id": "562", "name": "Bacterium coli"}, {"depth": 9, "id": "562", "name": "Bacterium coli commune"}, {"depth": 9, "id": "562", "name": "E. coli"}, {"depth": 9, "id": "562", "name": "Enterococcus coli"}, {"depth": 9, "id": "562", "name": "Escherichia/Shigella coli"}]}], "rcsb_entity_source_organism": [{"common_name": "human", "ncbi_common_names": ["human"], "ncbi_parent_scientific_name": "Eukaryota", "ncbi_scientific_name": "Homo sapiens", "ncbi_taxonomy_id": 9606, "pdbx_src_id": 1, "provenance_source": "Primary Data", "scientific_name": "Homo sapiens", "source_type": "genetically engineered", "taxonomy_lineage": [{"depth": 1, "id": "131567", "name": "cellular organisms"}, {"depth": 1, "id": "131567", "name": "biota"}, {"depth": 2, "id": "2759", "name": "Eukaryota"}, {"depth": 2, "id": "2759", "name": "Eucarya"}, {"depth": 2, "id": "2759", "name": "Eucaryotae"}, {"depth": 2, "id": "2759", "name": "Eukarya"}, {"depth": 2, "id": "2759", "name": "Eukaryotae"}, {"depth": 2, "id": "2759", "name": "eukaryotes"}, {"depth": 3, "id": "33154", "name": "Opisthokonta"}, {"depth": 3, "id": "33154", "name": "Fungi/Metazoa group"}, {"depth": 3, "id": "33154", "name": "opisthokonts"}, {"depth": 4, "id": "33208", "name": "Metazoa"}, {"depth": 4, "id": "33208", "name": "Animalia"}, {"depth": 4, "id": "33208", "name": "animals"}, {"depth": 4, "id": "33208", "name": "metazoans"}, {"depth": 4, "id": "33208", "name": "multicellular animals"}, {"depth": 5, "id": "6072", "name": "Eumetazoa"}, {"depth": 6, "id": "33213", "name": "Bilateria"}, {"depth": 7, "id": "33511", "name": "Deuterostomia"}, {"depth": 7, "id": "33511", "name": "deuterostomes"}, {"depth": 8, "id": "7711", "name": "Chordata"}, {"depth": 8, "id": "7711", "name": "chordates"}, {"depth": 9, "id": "89593", "name": "Craniata"}, {"depth": 10, "id": "7742", "name": "Vertebrata"}, {"depth": 10, "id": "7742", "name": "vertebrates"}, {"depth": 11, "id": "7776", "name": "Gnathostomata"}, {"depth": 11, "id": "7776", "name": "jawed vertebrates"}, {"depth": 12, "id": "117570", "name": "Teleostomi"}, {"depth": 13, "id": "117571", "name": "Euteleostomi"}, {"depth": 13, "id": "117571", "name": "bony vertebrates"}, {"depth": 14, "id": "8287", "name": "Sarcopterygii"}, {"depth": 15, "id": "1338369", "name": "Dipnotetrapodomorpha"}, {"depth": 16, "id": "32523", "name": "Tetrapoda"}, {"depth": 16, "id": "32523", "name": "tetrapods"}, {"depth": 17, "id": "32524", "name": "Amniota"}, {"depth": 17, "id": "32524", "name": "amniotes"}, {"depth": 18, "id": "40674", "name": "Mammalia"}, {"depth": 18, "id": "40674", "name": "mammals"}, {"depth": 19, "id": "32525", "name": "Theria"}, {"depth": 20, "id": "9347", "name": "Eutheria"}, {"depth": 20, "id": "9347", "name": "Placentalia"}, {"depth": 20, "id": "9347", "name": "eutherian mammals"}, {"depth": 20, "id": "9347", "name": "placental mammals"}, {"depth": 20, "id": "9347", "name": "placentals"}, {"depth": 21, "id": "1437010", "name": "Boreoeutheria"}, {"depth": 21, "id": "1437010", "name": "Boreotheria"}, {"depth": 22, "id": "314146", "name": "Euarchontoglires"}, {"depth": 23, "id": "9443", "name": "Primates"}, {"depth": 23, "id": "9443", "name": "Primata"}, {"depth": 23, "id": "9443", "name": "primate"}, {"depth": 23, "id": "9443", "name": "primates"}, {"depth": 24, "id": "376913", "name": "Haplorrhini"}, {"depth": 25, "id": "314293", "name": "Simiiformes"}, {"depth": 25, "id": "314293", "name": "Anthropoidea"}, {"depth": 26, "id": "9526", "name": "Catarrhini"}, {"depth": 27, "id": "314295", "name": "Hominoidea"}, {"depth": 27, "id": "314295", "name": "ape"}, {"depth": 27, "id": "314295", "name": "apes"}, {"depth": 28, "id": "9604", "name": "Hominidae"}, {"depth": 28, "id": "9604", "name": "Pongidae"}, {"depth": 28, "id": "9604", "name": "great apes"}, {"depth": 29, "id": "207598", "name": "Homininae"}, {"depth": 29, "id": "207598", "name": "Homo/Pan/Gorilla group"}, {"depth": 30, "id": "9605", "name": "Homo"}, {"depth": 30, "id": "9605", "name": "humans"}, {"depth": 31, "id": "9606", "name": "Homo sapiens"}, {"depth": 31, "id": "9606", "name": "human"}]}], "rcsb_genomic_lineage": [{"depth": 2, "id": "9606:6:glutathione_s_transferase_alpha_1", "name": "glutathione S-transferase alpha 1"}, {"depth": 1, "id": "9606:6", "name": "Chromosome 6"}, {"depth": 0, "id": "9606", "name": "Homo sapiens"}], "rcsb_polymer_entity": {"formula_weight": 25.686, "pdbx_description": "Glutathione S-transferase A1", "pdbx_ec": "2.5.1.18", "pdbx_number_of_molecules": 2, "rcsb_multiple_source_flag": "N", "rcsb_source_part_count": 1, "rcsb_source_taxonomy_count": 1, "src_method": "man", "rcsb_ec_lineage": [{"depth": 1, "id": "2", "name": "Transferases"}, {"depth": 2, "id": "2.5", "name": "Transferring alkyl or aryl groups, other than methyl groups"}, {"depth": 3, "id": "2.5.1", "name": "Transferring alkyl or aryl groups, other than methyl groups (only sub-subclass identified to date)"}, {"depth": 4, "id": "2.5.1.18", "name": "glutathione transferase"}, {"depth": 1, "id": "5", "name": "Isomerases"}, {"depth": 2, "id": "5.3", "name": "Intramolecular oxidoreductases"}, {"depth": 3, "id": "5.3.3", "name": "Transposing C=C bonds"}, {"depth": 1, "id": "1", "name": "Oxidoreductases"}, {"depth": 2, "id": "1.11", "name": "Acting on a peroxide as acceptor"}, {"depth": 3, "id": "1.11.1", "name": "Peroxidases"}], "rcsb_macromolecular_names_combined": [{"name": "Glutathione S-transferase A1", "provenance_code": "ECO:0000304", "provenance_source": "PDB Preferred Name"}, {"name": "GTH1", "provenance_code": "ECO:0000303", "provenance_source": "PDB Synonym"}, {"name": "HA SUBUNIT 1", "provenance_code": "ECO:0000303", "provenance_source": "PDB Synonym"}, {"name": "GST-EPSILON", "provenance_code": "ECO:0000303", "provenance_source": "PDB Synonym"}, {"name": "GSTA1-1", "provenance_code": "ECO:0000303", "provenance_source": "PDB Synonym"}, {"name": "GST CLASS-ALPHA", "provenance_code": "ECO:0000303", "provenance_source": "PDB Synonym"}], "rcsb_enzyme_class_combined": [{"depth": 4, "ec": "2.5.1.18", "provenance_source": "PDB Primary Data"}, {"depth": 3, "ec": "5.3.3", "provenance_source": "UniProt"}, {"depth": 3, "ec": "1.11.1", "provenance_source": "UniProt"}], "rcsb_polymer_name_combined": {"names": ["Glutathione S-transferase A1"], "provenance_source": "UniProt Name"}}, "rcsb_polymer_entity_align": [{"provenance_source": "SIFTS", "reference_database_accession": "P08263", "reference_database_name": "UniProt", "aligned_regions": [{"entity_beg_seq_id": 1, "length": 222, "ref_beg_seq_id": 1}]}], "rcsb_polymer_entity_annotation": [{"annotation_id": "PF00043", "assignment_version": "34.0", "name": "Glutathione S-transferase, C-terminal domain (GST_C)", "provenance_source": "Pfam", "type": "Pfam"}, {"annotation_id": "PF02798", "assignment_version": "34.0", "name": "Glutathione S-transferase, N-terminal domain (GST_N)", "provenance_source": "Pfam", "type": "Pfam"}, {"annotation_id": "IPR004046", "name": "Glutathione S-transferase, C-terminal", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 1, "id": "IPR010987", "name": "Glutathione S-transferase, C-terminal-like"}, {"depth": 2, "id": "IPR004046", "name": "Glutathione S-transferase, C-terminal"}]}, {"annotation_id": "GO:0006805", "name": "xenobiotic metabolic process", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0051716", "name": "cellular response to stimulus"}, {"id": "GO:0070887", "name": "cellular response to chemical stimulus"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0042221", "name": "response to chemical"}, {"id": "GO:0071466", "name": "cellular response to xenobiotic stimulus"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0006805", "name": "xenobiotic metabolic process"}, {"id": "GO:0009410", "name": "response to xenobiotic stimulus"}]}, {"annotation_id": "IPR010987", "name": "Glutathione S-transferase, C-terminal-like", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 1, "id": "IPR010987", "name": "Glutathione S-transferase, C-terminal-like"}]}, {"annotation_id": "IPR003080", "name": "Glutathione S-transferase, alpha class", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 2, "id": "IPR003080", "name": "Glutathione S-transferase, alpha class"}, {"depth": 1, "id": "IPR040079", "name": "Glutathione transferase family"}]}, {"annotation_id": "GO:0070062", "name": "extracellular exosome", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0070062", "name": "extracellular exosome"}, {"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:1903561", "name": "extracellular vesicle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0043230", "name": "extracellular organelle"}, {"id": "GO:0005576", "name": "extracellular region"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0005615", "name": "extracellular space"}, {"id": "GO:0031982", "name": "vesicle"}, {"id": "GO:0065010", "name": "extracellular membrane-bounded organelle"}]}, {"annotation_id": "IPR004045", "name": "Glutathione S-transferase, N-terminal", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 1, "id": "IPR004045", "name": "Glutathione S-transferase, N-terminal"}]}, {"annotation_id": "GO:0004602", "name": "glutathione peroxidase activity", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0004601", "name": "peroxidase activity"}, {"id": "GO:0016491", "name": "oxidoreductase activity"}, {"id": "GO:0016209", "name": "antioxidant activity"}, {"id": "GO:0016684", "name": "oxidoreductase activity, acting on peroxide as acceptor"}, {"id": "GO:0004602", "name": "glutathione peroxidase activity"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0003824", "name": "catalytic activity"}]}, {"annotation_id": "GO:0005829", "name": "cytosol", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0005737", "name": "cytoplasm"}, {"id": "GO:0005829", "name": "cytosol"}]}, {"annotation_id": "GO:0005504", "name": "fatty acid binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0005504", "name": "fatty acid binding"}, {"id": "GO:0043177", "name": "organic acid binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:0043167", "name": "ion binding"}, {"id": "GO:0043168", "name": "anion binding"}, {"id": "GO:0008289", "name": "lipid binding"}, {"id": "GO:0031406", "name": "carboxylic acid binding"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0033293", "name": "monocarboxylic acid binding"}, {"id": "GO:0036094", "name": "small molecule binding"}]}, {"annotation_id": "GO:0004364", "name": "glutathione transferase activity", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0004364", "name": "glutathione transferase activity"}, {"id": "GO:0016740", "name": "transferase activity"}, {"id": "GO:0016765", "name": "transferase activity, transferring alkyl or aryl (other than methyl) groups"}, {"id": "GO:0003824", "name": "catalytic activity"}, {"id": "GO:0003674", "name": "molecular_function"}]}, {"annotation_id": "GO:1901687", "name": "glutathione derivative biosynthetic process", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0044272", "name": "sulfur compound biosynthetic process"}, {"id": "GO:0009058", "name": "biosynthetic process"}, {"id": "GO:1901687", "name": "glutathione derivative biosynthetic process"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0006790", "name": "sulfur compound metabolic process"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}]}, {"annotation_id": "GO:0043651", "name": "linoleic acid metabolic process", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0006631", "name": "fatty acid metabolic process"}, {"id": "GO:0001676", "name": "long-chain fatty acid metabolic process"}, {"id": "GO:0033559", "name": "unsaturated fatty acid metabolic process"}, {"id": "GO:0043436", "name": "oxoacid metabolic process"}, {"id": "GO:0019752", "name": "carboxylic acid metabolic process"}, {"id": "GO:0044238", "name": "primary metabolic process"}, {"id": "GO:0006082", "name": "organic acid metabolic process"}, {"id": "GO:0043651", "name": "linoleic acid metabolic process"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0120254", "name": "olefinic compound metabolic process"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0044281", "name": "small molecule metabolic process"}, {"id": "GO:0032787", "name": "monocarboxylic acid metabolic process"}, {"id": "GO:0006629", "name": "lipid metabolic process"}]}, {"annotation_id": "GO:0006693", "name": "prostaglandin metabolic process", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0006693", "name": "prostaglandin metabolic process"}, {"id": "GO:0006690", "name": "icosanoid metabolic process"}, {"id": "GO:0006631", "name": "fatty acid metabolic process"}, {"id": "GO:0033559", "name": "unsaturated fatty acid metabolic process"}, {"id": "GO:0043436", "name": "oxoacid metabolic process"}, {"id": "GO:0019752", "name": "carboxylic acid metabolic process"}, {"id": "GO:0044238", "name": "primary metabolic process"}, {"id": "GO:0006082", "name": "organic acid metabolic process"}, {"id": "GO:0006692", "name": "prostanoid metabolic process"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0044281", "name": "small molecule metabolic process"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0032787", "name": "monocarboxylic acid metabolic process"}, {"id": "GO:0006629", "name": "lipid metabolic process"}]}, {"annotation_id": "GO:0030855", "name": "epithelial cell differentiation", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0032502", "name": "developmental process"}, {"id": "GO:0060429", "name": "epithelium development"}, {"id": "GO:0048869", "name": "cellular developmental process"}, {"id": "GO:0030154", "name": "cell differentiation"}, {"id": "GO:0048856", "name": "anatomical structure development"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0009888", "name": "tissue development"}, {"id": "GO:0030855", "name": "epithelial cell differentiation"}]}, {"annotation_id": "IPR050213", "name": "Glutathione S-transferase superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR050213", "name": "Glutathione S-transferase superfamily"}]}, {"annotation_id": "GO:0006749", "name": "glutathione metabolic process", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0006749", "name": "glutathione metabolic process"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0006575", "name": "modified amino acid metabolic process"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0006790", "name": "sulfur compound metabolic process"}, {"id": "GO:0043603", "name": "amide metabolic process"}]}, {"annotation_id": "IPR036282", "name": "Glutathione S-transferase, C-terminal domain superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR036282", "name": "Glutathione S-transferase, C-terminal domain superfamily"}]}, {"annotation_id": "IPR036249", "name": "Thioredoxin-like superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR036249", "name": "Thioredoxin-like superfamily"}]}, {"annotation_id": "GO:0004769", "name": "steroid Delta-isomerase activity", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0016853", "name": "isomerase activity"}, {"id": "GO:0016863", "name": "intramolecular oxidoreductase activity, transposing C=C bonds"}, {"id": "GO:0016860", "name": "intramolecular oxidoreductase activity"}, {"id": "GO:0003824", "name": "catalytic activity"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0004769", "name": "steroid Delta-isomerase activity"}]}, {"annotation_id": "IPR040079", "name": "Glutathione transferase family", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 1, "id": "IPR040079", "name": "Glutathione transferase family"}]}], "rcsb_polymer_entity_container_identifiers": {"asym_ids": ["A", "B"], "auth_asym_ids": ["A", "B"], "chem_comp_monomers": ["ALA", "ARG", "ASN", "ASP", "CSO", "GLN", "GLU", "GLY", "HIS", "ILE", "LEU", "LYS", "MET", "PHE", "PRO", "SER", "THR", "TRP", "TYR", "VAL"], "chem_comp_nstd_monomers": ["CSO"], "entity_id": "1", "entry_id": "1PKW", "rcsb_id": "1PKW_1", "uniprot_ids": ["P08263"], "reference_sequence_identifiers": [{"database_accession": "P08263", "database_name": "UniProt", "entity_sequence_coverage": 1.0, "provenance_source": "SIFTS", "reference_sequence_coverage": 1.0}]}, "rcsb_polymer_entity_feature": [{"assignment_version": "34.0", "feature_id": "PF02798", "name": "Glutathione S-transferase, N-terminal domain (GST_N)", "provenance_source": "Pfam", "type": "Pfam", "feature_positions": [{"beg_seq_id": 5, "end_seq_id": 77}]}, {"assignment_version": "34.0", "feature_id": "PF00043", "name": "Glutathione S-transferase, C-terminal domain (GST_C)", "provenance_source": "Pfam", "type": "Pfam", "feature_positions": [{"beg_seq_id": 99, "end_seq_id": 192}]}, {"assignment_version": "V1.0", "feature_id": "monomer_feature_1", "name": "Parent monomer CYS", "provenance_source": "PDB", "type": "modified_monomer", "feature_positions": [{"beg_seq_id": 112}], "additional_properties": [{"name": "PARENT_COMP_ID", "values": ["CYS"]}]}, {"assignment_version": "V1.0", "feature_id": "monomer_feature_2", "name": "modified residue", "provenance_source": "PDB", "type": "mutation", "feature_positions": [{"beg_seq_id": 112}]}, {"name": "Hydropathy values", "provenance_source": "biojava-7.2.4", "type": "hydropathy", "feature_positions": [{"beg_seq_id": 5, "values": [-1.1, -1.0, -1.59, -1.0, -1.07, -0.93, -1.0, -1.21, -1.24, -1.19, -1.58, -1.69, -1.99, -1.07, -0.6, 0.1, 0.09, 0.68, 0.72, 1.27, 1.38, 1.79, 0.98, 0.17, -0.47, -0.36, -0.06, -0.44, -1.0, -0.41, -1.11, -1.11, -0.3, -0.26, -1.0, -1.08, -1.14, -1.44, -2.03, -1.69, -1.44, -1.44, -0.84, -0.1, -0.91, -0.8, 0.06, 0.27, 0.52, 1.13, 0.32, 0.61, -0.09, 0.26, 0.86, -0.04, 0.56, 0.81, -0.04, 0.27, -0.73, -0.14, 0.4, 0.61, 0.66, 0.09, 0.12, 0.71, 0.7, 0.77, 0.42, -0.47, -0.47, -0.22, -0.12, -1.06, -1.64, -1.06, -1.06, -1.3, -1.41, -1.63, -1.07, -0.52, -0.48, 0.12, -0.52, 0.41, 0.41, 0.87, 1.17, 0.94, 0.06, 0.87, 0.61, 0.37, 0.08, 0.97, 1.43, 1.36, 1.58, 1.79, 1.83, 2.16, 2.37, 1.98, 1.09, 0.28, -0.58, -1.39, -1.01, -1.91, -1.77, -1.39, -0.79, 0.1, 0.06, 0.1, 0.06, 0.36, 0.36, -0.46, -1.16, -1.72, -1.91, -1.66, -1.07, -0.32, -1.21, -1.21, -0.36, 0.57, 0.28, -0.12, -0.3, -0.54, -1.24, -1.24, -0.96, -1.0, -0.96, -0.57, -0.87, -0.94, -0.48, -0.18, -0.29, 0.06, -0.76, -0.72, -1.03, -0.22, 0.68, -0.13, 0.38, 1.3, 0.96, 1.2, 1.17, 1.13, 0.32, 0.28, 0.28, -0.23, -0.74, -0.18, 0.47, -0.09, 0.21, 0.91, 0.31, 1.12, 1.63, 1.29, 1.07, 0.99, 0.64, 0.66, -0.16, 0.52, 0.01, -0.8, 0.06, -0.32, -0.82, 0.08, -0.28, -0.21, -0.4, 0.11, 0.11, -0.49, -0.36, -0.37, -1.01, -1.08, -1.08, -1.57, -2.17, -1.57, -1.78, -2.12, -2.47, -2.38, -1.46, -1.41, -1.62, -1.24, -1.96, -2.0, -1.11, -0.37, -0.78, -0.89]}]}, {"name": "Disordered regions", "provenance_source": "IUPred2(short)", "type": "disorder", "feature_positions": [{"beg_seq_id": 1, "values": [0.82, 0.75, 0.7, 0.67, 0.62, 0.54, 0.51, 0.47, 0.42, 0.38, 0.25, 0.23, 0.2, 0.17, 0.15, 0.11, 0.11, 0.12, 0.12, 0.11, 0.18, 0.19, 0.21, 0.14, 0.09, 0.09, 0.12, 0.1, 0.1, 0.11, 0.06, 0.12, 0.15, 0.13, 0.15, 0.17, 0.2, 0.2, 0.19, 0.12, 0.16, 0.09, 0.09, 0.1, 0.11, 0.19, 0.16, 0.11, 0.13, 0.07, 0.07, 0.12, 0.08, 0.08, 0.08, 0.06, 0.06, 0.05, 0.05, 0.07, 0.06, 0.04, 0.08, 0.04, 0.02, 0.03, 0.02, 0.03, 0.02, 0.02, 0.02, 0.01, 0.01, 0.01, 0.01, 0.01, 0.02, 0.02, 0.02, 0.02, 0.01, 0.01, 0.03, 0.02, 0.02, 0.02, 0.03, 0.03, 0.01, 0.02, 0.02, 0.02, 0.04, 0.04, 0.04, 0.02, 0.02, 0.01, 0.01, 0.01, 0.01, 0.01, 0.02, 0.02, 0.03, 0.06, 0.11, 0.11, 0.09, 0.16, 0.12, 0.1, 0.1, 0.06, 0.06, 0.08, 0.13, 0.12, 0.18, 0.27, 0.24, 0.25, 0.22, 0.21, 0.16, 0.09, 0.09, 0.09, 0.06, 0.04, 0.04, 0.07, 0.09, 0.13, 0.21, 0.22, 0.14, 0.09, 0.1, 0.1, 0.1, 0.1, 0.08, 0.13, 0.1, 0.1, 0.17, 0.09, 0.09, 0.07, 0.08, 0.08, 0.05, 0.03, 0.01, 0.01, 0.0, 0.01, 0.02, 0.01, 0.01, 0.01, 0.01, 0.01, 0.01, 0.01, 0.01, 0.0, 0.01, 0.01, 0.01, 0.01, 0.01, 0.01, 0.02, 0.04, 0.06, 0.05, 0.05, 0.05, 0.06, 0.07, 0.07, 0.05, 0.09, 0.17, 0.11, 0.07, 0.16, 0.15, 0.23, 0.32, 0.35, 0.38, 0.47, 0.5, 0.53, 0.51, 0.6, 0.59, 0.59, 0.66, 0.58, 0.57, 0.63, 0.61, 0.6, 0.68, 0.69, 0.63, 0.61, 0.55, 0.59, 0.6, 0.64, 0.67, 0.68, 0.69, 0.74, 0.78, 0.82, 0.85]}]}, {"name": "Disordered binding sites", "provenance_source": "Anchor2", "type": "disorder_binding", "feature_positions": [{"beg_seq_id": 1, "values": [0.4, 0.41, 0.42, 0.43, 0.42, 0.41, 0.41, 0.39, 0.36, 0.34, 0.31, 0.29, 0.28, 0.29, 0.29, 0.3, 0.31, 0.32, 0.33, 0.35, 0.37, 0.39, 0.39, 0.39, 0.37, 0.36, 0.34, 0.32, 0.3, 0.29, 0.27, 0.25, 0.23, 0.22, 0.21, 0.21, 0.2, 0.19, 0.19, 0.19, 0.18, 0.18, 0.19, 0.19, 0.19, 0.19, 0.19, 0.19, 0.2, 0.2, 0.19, 0.18, 0.17, 0.15, 0.14, 0.12, 0.11, 0.1, 0.09, 0.08, 0.07, 0.06, 0.06, 0.05, 0.05, 0.05, 0.05, 0.04, 0.04, 0.04, 0.04, 0.04, 0.04, 0.04, 0.05, 0.05, 0.05, 0.06, 0.06, 0.06, 0.07, 0.07, 0.07, 0.08, 0.08, 0.08, 0.08, 0.08, 0.08, 0.08, 0.07, 0.07, 0.07, 0.07, 0.07, 0.06, 0.06, 0.06, 0.05, 0.06, 0.06, 0.06, 0.07, 0.08, 0.08, 0.09, 0.11, 0.11, 0.12, 0.13, 0.13, 0.14, 0.14, 0.14, 0.14, 0.13, 0.13, 0.12, 0.11, 0.1, 0.1, 0.09, 0.09, 0.08, 0.08, 0.08, 0.08, 0.08, 0.08, 0.08, 0.08, 0.09, 0.09, 0.09, 0.09, 0.09, 0.1, 0.1, 0.1, 0.1, 0.1, 0.11, 0.11, 0.11, 0.12, 0.12, 0.13, 0.13, 0.12, 0.12, 0.12, 0.12, 0.11, 0.11, 0.11, 0.11, 0.11, 0.12, 0.13, 0.14, 0.15, 0.17, 0.2, 0.22, 0.25, 0.27, 0.28, 0.29, 0.31, 0.32, 0.34, 0.35, 0.36, 0.38, 0.38, 0.38, 0.39, 0.4, 0.39, 0.39, 0.38, 0.36, 0.35, 0.34, 0.32, 0.31, 0.3, 0.29, 0.28, 0.28, 0.28, 0.28, 0.28, 0.28, 0.28, 0.29, 0.3, 0.31, 0.32, 0.33, 0.33, 0.34, 0.35, 0.36, 0.36, 0.37, 0.38, 0.39, 0.38, 0.39, 0.4, 0.41, 0.42, 0.43, 0.43, 0.42, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4]}]}], "rcsb_polymer_entity_feature_summary": [{"count": 1, "coverage": 0.0045, "type": "modified_monomer"}, {"count": 1, "coverage": 0.0045, "type": "mutation"}, {"count": 2, "coverage": 0.75225, "type": "Pfam"}], "rcsb_polymer_entity_group_membership": [{"aggregation_method": "sequence_identity", "group_id": "1653_50", "similarity_cutoff": 50.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 222, "ref_beg_seq_id": 4}]}, {"aggregation_method": "matching_uniprot_accession", "group_id": "P08263", "aligned_regions": [{"entity_beg_seq_id": 1, "length": 222, "ref_beg_seq_id": 1}]}, {"aggregation_method": "sequence_identity", "group_id": "1012_30", "similarity_cutoff": 30.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 37, "ref_beg_seq_id": 68}, {"entity_beg_seq_id": 38, "length": 5, "ref_beg_seq_id": 113}, {"entity_beg_seq_id": 43, "length": 18, "ref_beg_seq_id": 122}, {"entity_beg_seq_id": 61, "length": 3, "ref_beg_seq_id": 141}, {"entity_beg_seq_id": 64, "length": 41, "ref_beg_seq_id": 149}, {"entity_beg_seq_id": 105, "length": 4, "ref_beg_seq_id": 191}, {"entity_beg_seq_id": 109, "length": 1, "ref_beg_seq_id": 200}, {"entity_beg_seq_id": 110, "length": 3, "ref_beg_seq_id": 203}, {"entity_beg_seq_id": 113, "length": 30, "ref_beg_seq_id": 207}, {"entity_beg_seq_id": 143, "length": 1, "ref_beg_seq_id": 238}, {"entity_beg_seq_id": 144, "length": 28, "ref_beg_seq_id": 241}, {"entity_beg_seq_id": 172, "length": 9, "ref_beg_seq_id": 276}, {"entity_beg_seq_id": 181, "length": 6, "ref_beg_seq_id": 286}, {"entity_beg_seq_id": 187, "length": 36, "ref_beg_seq_id": 293}]}, {"aggregation_method": "sequence_identity", "group_id": "3739_100", "similarity_cutoff": 100.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 222, "ref_beg_seq_id": 1}]}, {"aggregation_method": "sequence_identity", "group_id": "1870_90", "similarity_cutoff": 90.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 222, "ref_beg_seq_id": 4}]}, {"aggregation_method": "sequence_identity", "group_id": "1518_70", "similarity_cutoff": 70.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 222, "ref_beg_seq_id": 4}]}, {"aggregation_method": "sequence_identity", "group_id": "2079_95", "similarity_cutoff": 95.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 222, "ref_beg_seq_id": 4}]}], "rcsb_polymer_entity_name_com": [{"name": "GTH1, HA SUBUNIT 1, GST-EPSILON, GSTA1-1, GST CLASS-ALPHA"}], "rcsb_related_target_references": [{"related_resource_name": "ChEMBL", "related_resource_version": "36", "related_target_id": "CHEMBL3409", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 221, "target_beg_seq_id": 1}]}, {"related_resource_name": "ChEMBL", "related_resource_version": "36", "related_target_id": "CHEMBL2241", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 221, "target_beg_seq_id": 1}]}, {"related_resource_name": "DrugBank", "related_resource_version": "5.1", "related_target_id": "P09210", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 221, "target_beg_seq_id": 1}]}, {"related_resource_name": "DrugBank", "related_resource_version": "5.1", "related_target_id": "P08263", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 221, "target_beg_seq_id": 1}]}, {"related_resource_name": "Pharos", "related_resource_version": "6.13.4", "related_target_id": "17594", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 221, "target_beg_seq_id": 1}]}, {"related_resource_name": "Pharos", "related_resource_version": "6.13.4", "related_target_id": "17526", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 221, "target_beg_seq_id": 1}]}], "rcsb_target_cofactors": [{"binding_assay_value": 3.98, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "JDNMAGZNSICFGF-UHFFFAOYSA-N", "cofactor_smiles": "CCCCOc1c2cccc1Cc1cc(C(=O)P(=O)(O)O)cc(c1O)Cc1cccc(c1OCCCC)Cc1cc(C(=O)P(=O)(O)O)cc(c1O)C2", "cofactor_resource_id": "CHEMBL5174343", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3409"}, {"binding_assay_value": 3.98, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "GBJJMLCSNHLVQI-UHFFFAOYSA-N", "cofactor_smiles": "CCCOc1c2cccc1Cc1cc(C(=O)P(=O)(O)O)cc(c1O)Cc1cccc(c1OCCC)Cc1cc(C(=O)P(=O)(O)O)cc(c1O)C2", "cofactor_resource_id": "CHEMBL5199600", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3409"}, {"binding_assay_value": 3.86, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "MUYUWUWMFGWOBW-UHFFFAOYSA-N", "cofactor_smiles": "C=C(CC)C(=O)c1ccc(OCC(=O)NCCCC(=O)NCc2cccc(C(N)=O)c2)c(Cl)c1Cl", "cofactor_resource_id": "CHEMBL212517", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3409"}, {"binding_assay_value": 3.83, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "BXJSPWKYSSRFEB-UHFFFAOYSA-N", "cofactor_smiles": "NC(CCC(=O)NC(CSCc1ccc(Cl)cc1)C(=O)NC(C(=O)O)c1ccccc1)C(=O)O", "cofactor_resource_id": "CHEMBL442360", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3409"}, {"binding_assay_value": 3.61, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "ZPSKWMFLCHMEOY-UHFFFAOYSA-N", "cofactor_smiles": "NC(CCC(=O)NC(CSCc1ccccc1)C(=O)NC(C(=O)O)c1ccccc1)C(=O)O", "cofactor_resource_id": "CHEMBL58951", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3409"}, {"binding_assay_value": 3.37, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "MBXWAPNNAOGFPH-UHFFFAOYSA-N", "cofactor_smiles": "Cc1ccc(CSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCCC(=O)O)cc1", "cofactor_resource_id": "CHEMBL301229", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3409"}, {"binding_assay_value": 3.37, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "RILVFYFKIDXJNY-UHFFFAOYSA-N", "cofactor_smiles": "CCCCCCSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCCC(=O)O", "cofactor_resource_id": "CHEMBL60581", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3409"}, {"binding_assay_value": 3.15, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "YSCKROBNICXBFG-DEDYPNTBSA-N", "cofactor_smiles": "Cn1cccc1S(=O)(=O)Cc1ccccc1/N=C/c1ccc([N+](=O)[O-])cc1", "cofactor_resource_id": "CHEMBL2165141", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3409"}, {"binding_assay_value": 2.87, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "NETPMDDWGFTNKZ-UHFFFAOYSA-N", "cofactor_smiles": "Cn1cccc1S(=O)(=O)Cc1ccccc1[N+](=O)[O-]", "cofactor_resource_id": "CHEMBL2165146", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3409"}, {"binding_assay_value": 2.44, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "QLVGMERIDWMEBM-UHFFFAOYSA-N", "cofactor_smiles": "NC(CCC(=O)NC(CSCc1ccccc1)C(=O)NCCC(=O)O)C(=O)O", "cofactor_resource_id": "CHEMBL58451", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3409"}, {"binding_assay_value": 3.0, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "VIYYZYCLMFHOMO-HGNGGELXSA-N", "cofactor_smiles": "CO[C@H]1C=C(COC(C)=O)C(=O)[C@H](O)[C@H]1O", "cofactor_resource_id": "CHEMBL1938629", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2241"}, {"binding_assay_value": 3.0, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "AFUYITFFCLEQCI-BGNCJLHMSA-N", "cofactor_smiles": "CO[C@]1(C)O[C@H]2[C@H](O)C=C(COC(C)=O)C(=O)[C@@H]2O[C@@]1(C)OC", "cofactor_resource_id": "CHEMBL1938626", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2241"}, {"binding_assay_value": 3.0, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "JEELIVKAMVYZTM-DZQJYWQESA-N", "cofactor_smiles": "CO[C@@H]1C=C(COC(C)=O)C(=O)[C@@H]2O[C@@](C)(OC)[C@](C)(OC)O[C@@H]12", "cofactor_resource_id": "CHEMBL1938627", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2241"}, {"binding_assay_value": 2.84, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "LTTIKUNFSHFFDR-UHFFFAOYSA-N", "cofactor_smiles": "CCCOC(=O)CC(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C(=O)OCCC", "cofactor_resource_id": "CHEMBL176946", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2241"}, {"binding_assay_value": 2.75, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "PNGLORQYJBAEMH-NFSRCLSHSA-N", "cofactor_smiles": "CO[C@]1(C)O[C@H]2[C@@H](OC/C=C(\\C)CCC=C(C)C)C=C(COC(C)=O)C(=O)[C@@H]2O[C@@]1(C)OC", "cofactor_resource_id": "CHEMBL1938637", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2241"}, {"binding_assay_value": 2.66, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "VWJBEXOFRIALNB-UHFFFAOYSA-N", "cofactor_smiles": "NC(CCC(=O)NC(CSC1CCCC(=O)C1)C(=O)NCC(=O)O)C(=O)O", "cofactor_resource_id": "CHEMBL175098", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2241"}, {"binding_assay_value": 2.6, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "HROUCKBOKAXXIU-UHFFFAOYSA-N", "cofactor_smiles": "COC(=O)CC(SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C(=O)OC", "cofactor_resource_id": "CHEMBL174379", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL2241"}, {"cofactor_in_ch_ikey": "RWSXRVCMGQZWBV-WDSKDSINSA-N", "cofactor_smiles": "N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O", "cofactor_chem_comp_id": "GSH", "cofactor_name": "Glutathione", "cofactor_resource_id": "DB00143", "mechanism_of_action": "Glutathione (GSH) participates in leukotriene synthesis and is a cofactor for the enzyme glutathione peroxidase. It also plays a role in the hepatic biotransformation and detoxification process; it acts as a hydrophilic molecule that is added to other lipophilic toxins or wastes prior to entering biliary excretion. It participates in the detoxification of methylglyoxal, a toxic by-product of metabolism, mediated by glyoxalase enzymes.  Glyoxalase I catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-Lactoyl-glutathione. Glyoxalase II catalyzes the conversion of S-D-Lactoyl Glutathione to Reduced Glutathione and D-lactate. Glyoxalase I catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-Lactoyl-glutathione. Glyoxalase II catalyzes the conversion of S-D-Lactoyl Glutathione to Reduced Glutathione and D-lactate. GSH is a cofactor of conjugation and reduction reactions that are catalyzed by glutathione S-transferase enzymes expressed in the cytosol, microsomes, and mitochondria. However, it is capable of participating in non-enzymatic conjugation with some chemicals, as it is hypothesized to do to a significant extent with n-acetyl-p-benzoquinone imine (NAPQI), the reactive cytochrome P450 reactive metabolite formed by toxic overdose of acetaminophen. Glutathione in this capacity binds to NAPQI as a suicide substrate and in the process detoxifies it, taking the place of cellular protein sulfhydryl groups which would otherwise be toxically adducted. The preferred medical treatment to an overdose of this nature, whose efficacy has been consistently supported in literature, is the administration (usually in atomized form) of N-acetylcysteine, which is used by cells to replace spent GSSG and allow a usable GSH pool.", "neighbor_flag": "Y", "pubmed_ids": [17317527, 17321661, 17338280, 17338281, 17401685], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P09210"}, {"cofactor_in_ch_ikey": "GVJHHUAWPYXKBD-IEOSBIPESA-N", "cofactor_smiles": "CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C", "cofactor_chem_comp_id": "VIV", "cofactor_name": "Vitamin E", "cofactor_resource_id": "DB00163", "mechanism_of_action": "The mechanism of action for most of vitamin E's effects are still unknown[A176104,A176107]. Vitamin E is an antioxidant, preventing free radical reactions with cell membranes[A176360]. Though in some cases vitamin E has been shown to have pro-oxidant activity[A176360].\r\n\r\nOne mechanism of vitamin E's antioxidant effect is in the termination of lipid peroxidation[A176363]. Vitamin E reacts with unstable lipid radicals, producing stable lipids and a relatively stable vitamin E radical[A176363]. The vitamin E radical is then reduced back to stable vitamin E by reaction with ascorbate or glutathione[A176363].", "neighbor_flag": "N", "pubmed_ids": [20153624], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P09210"}, {"cofactor_in_ch_ikey": "WHTVZRBIWZFKQO-UHFFFAOYSA-N", "cofactor_smiles": "CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12", "cofactor_chem_comp_id": "CLQ", "cofactor_name": "Chloroquine", "cofactor_resource_id": "DB00608", "mechanism_of_action": "Chloroquine inhibits the action of heme polymerase in malarial trophozoites, preventing the conversion of heme to hemazoin.[A191700,A183080,A191781] _Plasmodium_ species continue to accumulate toxic heme, killing the parasite.[A191700]\r\n\r\nChloroquine passively diffuses through cell membranes and into endosomes, lysosomes, and Golgi vesicles; where it becomes protonated, trapping the chloroquine in the organelle and raising the surrounding pH.[A191676,A191628] The raised pH in endosomes, prevent virus particles from utilizing their activity for fusion and entry into the cell.[A191625]\r\n\r\nChloroquine does not affect the level of ACE2 expression on cell surfaces, but inhibits terminal glycosylation of ACE2, the receptor that SARS-CoV and SARS-CoV-2 target for cell entry.[A191628,A191625] ACE2 that is not in the glycosylated state may less efficiently interact with the SARS-CoV-2 spike protein, further inhibiting viral entry.[A191625]", "neighbor_flag": "N", "pubmed_ids": [11752352, 9385457], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P09210"}, {"cofactor_in_ch_ikey": "KNHUKKLJHYUCFP-UHFFFAOYSA-N", "cofactor_smiles": "CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1", "cofactor_name": "Clofibrate", "cofactor_resource_id": "DB00636", "mechanism_of_action": "Clofibrate increases the activity of extrahepatic lipoprotein lipase (LL), thereby increasing lipoprotein triglyceride lipolysis. Chylomicrons are degraded, VLDLs are converted to LDLs, and LDLs are converted to HDL. This is accompanied by a slight increase in secretion of lipids into the bile and ultimately the intestine. Clofibrate also inhibits the synthesis and increases the clearance of apolipoprotein B, a carrier molecule for VLDL. Also, as a fibrate, Clofibrate is an agonist of the PPAR-\u03b1 receptor[4] in muscle, liver, and other tissues. This agonism ultimately leads to modification in gene expression resulting in increased beta-oxidation, decreased triglyceride secretion, increased HDL, increased lipoprotein lipase activity.", "neighbor_flag": "N", "pubmed_ids": [3707598, 6477642], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P09210"}, {"cofactor_in_ch_ikey": "AVOLMBLBETYQHX-UHFFFAOYSA-N", "cofactor_smiles": "CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1", "cofactor_chem_comp_id": "EAA", "cofactor_name": "Etacrynic acid", "cofactor_resource_id": "DB00903", "mechanism_of_action": "Ethacrynic acid inhibits symport of sodium, potassium, and chloride primarily in the ascending limb of Henle, but also in the proximal and distal tubules. This pharmacological action results in excretion of these ions, increased urinary output, and reduction in extracellular fluid. Diuretics also lower blood pressure initially by reducing plasma and extracellular fluid volume; cardiac output also decreases, explaining its antihypertensive action. Eventually, cardiac output returns to normal with an accompanying decrease in peripheral resistance. Its mode of action does not involve carbonic anhydrase inhibition.", "neighbor_flag": "Y", "pubmed_ids": [15999103, 8329448, 8950226, 9463521, 9776312], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P09210"}, {"cofactor_in_ch_ikey": "LMEKQMALGUDUQG-UHFFFAOYSA-N", "cofactor_smiles": "CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O", "cofactor_name": "Azathioprine", "cofactor_resource_id": "DB00993", "mechanism_of_action": "Azathioprine's mechanism of action is not entirely understood but it may be related to inhibition of purine synthesis, along with inhibition of B and T cells.[A19872]\r\n\r\n6-thioguanine triphosphate, a metabolite of azathioprine, modulates activation of rac1 when costimulated with CD28, inducing T cell apoptosis.[A19872] This may be mediated through rac1's action on mitogen-activated protein kinase, NF-kappaB.[A19872]", "neighbor_flag": "N", "pubmed_ids": [24707136], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P09210"}, {"cofactor_in_ch_ikey": "COVZYZSDYWQREU-UHFFFAOYSA-N", "cofactor_smiles": "CS(=O)(=O)OCCCCOS(C)(=O)=O", "cofactor_name": "Busulfan", "cofactor_resource_id": "DB01008", "mechanism_of_action": "Busulfan is an alkylating agent that contains 2 labile methanesulfonate groups attached to opposite ends of a 4-carbon alkyl chain. Once busulfan is hydrolyzed, the methanesulfonate groups are released and carbonium ions are produced. These carbonium ions alkylate DNA, which results in the interference of DNA replication and RNA transcription, ultimately leading to the disruption of nucleic acid function. Specifically, its mechanism of action through alkylation produces guanine-adenine intrastrand crosslinks. These crosslinks occur through a SN2 reaction guanine N7 nucleophilically attacks the carbon adjacent to the mesylate leaving group. This kind of damage cannot be repaired by cellular machinery and thus the cell undergoes apoptosis.", "neighbor_flag": "N", "pubmed_ids": [18194479], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P09210"}, {"cofactor_in_ch_ikey": "IELOKBJPULMYRW-NJQVLOCASA-N", "cofactor_smiles": "[H][C@@](C)(CCCC(C)C)CCC[C@@]([H])(C)CCC[C@]1(C)CCC2=C(C)C(OC(=O)CCC(O)=O)=C(C)C(C)=C2O1", "cofactor_name": "alpha-Tocopherol succinate", "cofactor_resource_id": "DB14001", "mechanism_of_action": "Without further evidence to suggest otherwise, alpha-tocpherol succinate is generally believed to undergo a logical de-esterification in the gastrointestinal tract before being subsequently absorbed as free tocopherol [A32956, A32957]. The free alpha-tocopherol is therefore available and capable of the following activities.\r\n\r\nVitamin E's antioxidant capabilities are perhaps the primary biological action associated with alpha-tocopherol. In general, antioxidants protect cells from the damaging effects of free radicals, which are molecules that consist of an unshared electron [L2120]. These unshared electrons are highly energetic and react rapidly with oxygen to form reactive oxygen species (ROS) [L2120]. In doing so, free radicals are capable of damaging cells, which may facilitate their contribution to the development of various diseases [L2120]. Moreover, the human body naturally forms ROS when it converts food into energy and is also exposed to environmental free radicals contained in cigarette smoke, air pollution, or ultraviolet radiation from the sun [L2120]. It is believed that perhaps vitamin E antioxidants might be able to protect body cells from the damaging effects of such frequent free radical and ROS exposure [L2120].\r\n\r\nSpecifically, vitamin E is a chain-breaking antioxidant that prevents the propagation of free radical reactions [T166]. The vitamin E molecule is specifically a peroxyl radical scavenger and especially protects polyunsaturated fatty acids within endogenous cell membrane phospholipids and plasma lipoproteins [T166]. Peroxyl free radicals react with vitamin E a thousand times more rapidly than they do with the aforementioned polyunsaturated fatty acids [T166]. Furthermore, the phenolic hydroxyl group of tocopherol reacts with an organic peroxyl radical to form an organic hydroperoxide and tocopheroxyl radical [T166]. This tocopheroxyl radical can then undergo various possible reactions: it could (a) be reduced by other antioxidants to tocopherol, (b) react with another tocopheroxyl radical to form non-reactive products like tocopherol dimers, (c) undergo further oxidation to tocopheryl quinone, or (d) even act as a prooxidant and oxidize other lipids [T166].\r\n\r\nIn addition to the antioxidant actions of vitamin E, there have been a number of studies that report various other specific molecular functions associated with vitamin E [T166]. For example, alpha-tocopherol is capable of inhibiting protein kinase C activity, which is involved in cell proliferation and differentiation in smooth muscle cells, human platelets, and monocytes [T166]. In particular, protein kinase C inhibition by alpha-tocopherol is partially attributable to its attenuating effect on the generation of membrane-derived dialglycerol, a lipid that facilitates protein kinase C translocation, thereby increasing its activity [T166].\r\n\r\nIn addition, vitamin E enrichment of endothelial cells downregulates the expression of intercellular cell adhesion molecule (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), thereby decreasing the adhesion of blood cell components to the endothelium [T166].\r\n\r\nVitamin E also upregulates the expression of cytosolic phospholipase A2 and cyclooxygenase-1 [T166]. The increased expression of these two rate-limiting enzymes in the arachidonic acid cascade explains the observation that vitamin E, in a dose-dependent fashion, enhanced the release of prostacyclin, a potent vasodilator and inhibitor of platelet aggregation in humans [T166].\r\n\r\nFurthermore, vitamin E can inhibit platelet adhesion, aggregation, and platelet release reactions [T166]. The vitamin can also evidently inhibit the plasma generation of thrombin, a potent endogenous hormone that binds to platelet receptors and induces aggregation of platelets [T166]. Moreover, vitamin E may also be able to decrease monocyte adhesion to the endothellium by downregulating expression of adhesion molecules and decreasing monocyte superoxide production [T166].\r\n\r\nGiven these proposed biological activities of vitamin E, the substance continues to generate ongoing interest and studies in whether or not vitamin E can assist in delaying or preventing various diseases with any one or more of its biologic actions. For instance, studies continue to see whether vitamin E's ability to inhibit low-density lipoprotein oxidation can aid in preventing the development of cardiovascular disease or atherogenesis [T166].\r\n\r\nSimilarly, it is also believed that if vitamin E can decrease the chance of cardiovascular disease then it can also decrease the chance of related diabetic disease and complications [T166]. In much the same way, it is also believed that perhaps the antioxidant abilities of vitamin E can neutralize free radicals that are constantly reacting and damaging cellular DNA [T166]. Furthermore, it is also believed that free radical damage does contribute to protein damage in the ocular lens - another free radical-mediated condition that may potentially be prevented by vitamin E use [T166]. Where it is also suggested that various central nervous system disorders like Parkinson's disease, Alzheimer's disease, Down's syndrome, and Tardive Dyskinesia possess some form of oxidative stress component, it is also proposed that perhaps vitamin E use could assist with its antioxidant action [T166].\r\n\r\nThere have also been studies that report the possibility of vitamin E supplementation can improve or reverse the natural decline in cellular immune function in healthy, elderly individuals [T166].\r\n\r\nAs of this time, however, there is either only insufficient data or even contradicting data (where certain doses of vitamin E supplementation could even potentially increase all-cause mortality) [A237] on which to suggest the use of vitamin E could formally benefit in any of these proposed indications.\r\n\r\nFurthermore, there are ongoing studies that demonstrate alpha-tocopherol succinate's unique possession of capabilities that allow it to induce differentiation, inhibit proliferation and apoptosis in cancer cells, enhance the growth-inhibitory effect of ionizing radiation, hyperthermia, and some chemotherapeutic agents and biological response modifiers on tumor cells, all the while protecting normal cells against any adverse effects [A32959]. Despite being able to demonstrate such effects on animal and human cells in culture, the value of these effects has not drawn significant attention from researchers and clinicians and nor has the specific mechanisms of action been elucidated [A32959]. Additionally, other studies have also shown that alpha-tocopherol succinate seemingly possesses an ability exclusive from other tocopherol esters to inhibit and minimize prostaglandin E2 production in human lung epithelial cells [A32958]. Considering increased prostaglandin E2 production has been observed frequently in lung cancer patients, there may be another avenue in which alpha-tocopherol succinate may be able to treat lung cancer [A32958]. Nevertheless, the possibility of such activity requires further elucidation.", "neighbor_flag": "N", "pubmed_ids": [20153624], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P09210"}, {"cofactor_in_ch_ikey": "ZAKOWWREFLAJOT-CEFNRUSXSA-N", "cofactor_smiles": "CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1", "cofactor_name": "D-alpha-Tocopherol acetate", "cofactor_resource_id": "DB14002", "mechanism_of_action": "_In addition to any following information, owing to d-alpha-Tocopherol acetate's closely related chemical nature with alpha-Tocopherol acetate, please also refer to the drug information page for alpha-Tocopherol acetate for further data._\r\n\r\nAlthough all forms of Vitamin E exhibit antioxidant activity, it is known that the antioxidant activity of vitamin E is not sufficient to explain the vitamin's biological activity. <br/>Vitamin E's anti-atherogenic activity involves the inhibition of the oxidation of LDL and the accumulation of oxLDL in the arterial wall. It also appears to reduce oxLDL-induced apoptosis in human endothelial cells. Oxidation of LDL is a key early step in atherogenesis as it triggers a number of events which lead to the formation of atherosclerotic plaque. In addition, vitamin E inhibits protein kinase C (PKC) activity. PKC plays a role in smooth muscle cell proliferation, and, thus, the inhibition of PKC results in inhibition of smooth muscle cell proliferation, which is involved in atherogenesis. <br/>Vitamin E's antithrombotic and anticoagulant activities involves the downregulation of the expression of intracellular cell adhesion molecule(ICAM)-1 and vascular cell adhesion molecule(VCAM)-1 which lowers the adhesion of blood components to the endothelium. In addition, vitamin E upregulates the expression of cytosolic phospholipase A2 and cyclooxygenase (COX)-1 which in turn enhances the release of prostacyclin. Prostacyclin is a vasodilating factor and inhibitor of platelet aggregation and platelet release. It is also known that platelet aggregation is mediated by a mechanism involving the binding of fibrinogen to the glycoprotein IIb/IIIa (GPIIb/IIIa) complex of platelets. GPIIb/IIIa is the major membrane receptor protein that is key to the role of the platelet aggregation response. GPIIb is the alpha-subunit of this platelet membrane protein. Alpha-tocopherol downregulates GPIIb promoter activity which results in reduction of GPIIb protein expression and decreased platelet aggregation. Vitamin E has also been found in culture to decrease plasma production of thrombin, a protein which binds to platelets and induces aggregation. A metabolite of vitamin E called vitamin E quinone or alpha-tocopheryl quinone (TQ) is a potent anticoagulant. This metabolite inhibits vitamin K-dependent carboxylase, which is a major enzyme in the coagulation cascade.<br/>The neuroprotective effects of vitamin E are explained by its antioxidant effects. Many disorders of the nervous system are caused by oxidative stress. Vitamin E protects against this stress, thereby protecting the nervouse system. <br/>The immunomodulatory effects of Vitamin E have been demonstrated in vitro, where alpha-tocopherol increases mitogenic response of T lymphocytes from aged mice. The mechanism of this response by vitamin E is not well understood, however it has been suggested that vitamin E itself may have mitogenic activity independent of its antioxidant activity. <br/>Lastly, the mechanism of action of vitamin E's antiviral effects (primarily against HIV-1) involves its antioxidant activity. Vitamin E reduces oxidative stress, which is thought to contribute to HIV-1 pathogenesis, as well as to the pathogenesis of other viral infections. Vitamin E also affects membrane integrity and fluidity and, since HIV-1 is a membraned virus, altering membrane fluidity of HIV-1 may interfere with its ability to bind to cell-receptor sites, thus decreasing its infectivity.", "neighbor_flag": "N", "pubmed_ids": [20153624], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P09210"}, {"cofactor_in_ch_ikey": "RWSXRVCMGQZWBV-WDSKDSINSA-N", "cofactor_smiles": "N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O", "cofactor_chem_comp_id": "GSH", "cofactor_name": "Glutathione", "cofactor_resource_id": "DB00143", "mechanism_of_action": "Glutathione (GSH) participates in leukotriene synthesis and is a cofactor for the enzyme glutathione peroxidase. It also plays a role in the hepatic biotransformation and detoxification process; it acts as a hydrophilic molecule that is added to other lipophilic toxins or wastes prior to entering biliary excretion. It participates in the detoxification of methylglyoxal, a toxic by-product of metabolism, mediated by glyoxalase enzymes.  Glyoxalase I catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-Lactoyl-glutathione. Glyoxalase II catalyzes the conversion of S-D-Lactoyl Glutathione to Reduced Glutathione and D-lactate. Glyoxalase I catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-Lactoyl-glutathione. Glyoxalase II catalyzes the conversion of S-D-Lactoyl Glutathione to Reduced Glutathione and D-lactate. GSH is a cofactor of conjugation and reduction reactions that are catalyzed by glutathione S-transferase enzymes expressed in the cytosol, microsomes, and mitochondria. However, it is capable of participating in non-enzymatic conjugation with some chemicals, as it is hypothesized to do to a significant extent with n-acetyl-p-benzoquinone imine (NAPQI), the reactive cytochrome P450 reactive metabolite formed by toxic overdose of acetaminophen. Glutathione in this capacity binds to NAPQI as a suicide substrate and in the process detoxifies it, taking the place of cellular protein sulfhydryl groups which would otherwise be toxically adducted. The preferred medical treatment to an overdose of this nature, whose efficacy has been consistently supported in literature, is the administration (usually in atomized form) of N-acetylcysteine, which is used by cells to replace spent GSSG and allow a usable GSH pool.", "neighbor_flag": "Y", "pubmed_ids": [17425746, 17346923, 17333241, 10592235], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "JCKYGMPEJWAADB-UHFFFAOYSA-N", "cofactor_smiles": "OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl", "cofactor_chem_comp_id": "CBL", "cofactor_name": "Chlorambucil", "cofactor_resource_id": "DB00291", "mechanism_of_action": "Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations.", "neighbor_flag": "N", "pubmed_ids": [8950221], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "KRMDCWKBEZIMAB-UHFFFAOYSA-N", "cofactor_smiles": "CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12", "cofactor_chem_comp_id": "TP0", "cofactor_name": "Amitriptyline", "cofactor_resource_id": "DB00321", "mechanism_of_action": "The mechanism of action of this drug is not fully elucidated. It is suggested that amitriptyline inhibits the membrane pump mechanism responsible for the re-uptake of transmitter amines, such as norepinephrine and serotonin, thereby increasing their concentration at the synaptic clefts of the brain [FDA label], [A174673].   These amines are important in regulating mood.  The monoamine hypothesis in depression, one of the oldest hypotheses, postulates that deficiencies of serotonin (5-HT) and/or norepinephrine (NE) neurotransmission in the brain lead to depressive effects [A174670].   This drug counteracts these mechanisms, and this may be the mechanism of amitriptyline in improving depressive symptoms.\r\n\r\nWhether its analgesic effects are related to its mood-altering activities or attributable to a different, less obvious pharmacological action (or a combination of both) is unknown [A174661].", "neighbor_flag": "N", "pubmed_ids": [21567209], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "LMEKQMALGUDUQG-UHFFFAOYSA-N", "cofactor_smiles": "CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O", "cofactor_name": "Azathioprine", "cofactor_resource_id": "DB00993", "mechanism_of_action": "Azathioprine's mechanism of action is not entirely understood but it may be related to inhibition of purine synthesis, along with inhibition of B and T cells.[A19872]\r\n\r\n6-thioguanine triphosphate, a metabolite of azathioprine, modulates activation of rac1 when costimulated with CD28, inducing T cell apoptosis.[A19872] This may be mediated through rac1's action on mitogen-activated protein kinase, NF-kappaB.[A19872]", "neighbor_flag": "N", "pubmed_ids": [24707136, 30987408], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "COVZYZSDYWQREU-UHFFFAOYSA-N", "cofactor_smiles": "CS(=O)(=O)OCCCCOS(C)(=O)=O", "cofactor_name": "Busulfan", "cofactor_resource_id": "DB01008", "mechanism_of_action": "Busulfan is an alkylating agent that contains 2 labile methanesulfonate groups attached to opposite ends of a 4-carbon alkyl chain. Once busulfan is hydrolyzed, the methanesulfonate groups are released and carbonium ions are produced. These carbonium ions alkylate DNA, which results in the interference of DNA replication and RNA transcription, ultimately leading to the disruption of nucleic acid function. Specifically, its mechanism of action through alkylation produces guanine-adenine intrastrand crosslinks. These crosslinks occur through a SN2 reaction guanine N7 nucleophilically attacks the carbon adjacent to the mesylate leaving group. This kind of damage cannot be repaired by cellular machinery and thus the cell undergoes apoptosis.", "neighbor_flag": "N", "pubmed_ids": [16448639, 20672371, 18194479], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "FXIRVRPOOYSARH-REOHCLBHSA-N", "cofactor_smiles": "N[C@@H](CSO)C(O)=O", "cofactor_chem_comp_id": "CSO", "cofactor_name": "S-Hydroxycysteine", "cofactor_resource_id": "DB01915", "neighbor_flag": "N", "pubmed_ids": [10592235], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "KYNFOMQIXZUKRK-UHFFFAOYSA-N", "cofactor_smiles": "OCCSSCCO", "cofactor_chem_comp_id": "HED", "cofactor_name": "2-Hydroxyethyl Disulfide", "cofactor_resource_id": "DB02486", "neighbor_flag": "Y", "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "OMOPDEZZBQHMGS-AWEZNQCLSA-N", "cofactor_smiles": "[H]N([H])CCCC(=O)N([H])[C@@H](CSCC1=CC=C(OC)C=C1)C(=O)N([H])CC(O)=O", "cofactor_chem_comp_id": "ABY", "cofactor_name": "N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine", "cofactor_resource_id": "DB02943", "neighbor_flag": "Y", "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "QGWRMTHFAZVWAM-WDSKDSINSA-N", "cofactor_smiles": "[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CS(O)(=O)=O)C(=O)N([H])CC(O)=O)C(O)=O", "cofactor_chem_comp_id": "GTS", "cofactor_name": "Glutathione sulfonic acid", "cofactor_resource_id": "DB03003", "neighbor_flag": "N", "pubmed_ids": [10592235], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "YPZRWBKMTBYPTK-BJDJZHNGSA-N", "cofactor_smiles": "N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O)C(=O)NCC(O)=O)C(O)=O", "cofactor_chem_comp_id": "GDS", "cofactor_name": "Glutathione disulfide", "cofactor_resource_id": "DB03310", "neighbor_flag": "N", "pubmed_ids": [2492517], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "XYJWEQWNNKNSFU-STQMWFEESA-N", "cofactor_smiles": "[H]N([H])[C@@H](CCC(=O)N([H])[C@@H](CSCC1=CC=CC=C1)C(=O)N([H])CC(O)=O)C(O)=O", "cofactor_chem_comp_id": "GSB", "cofactor_name": "S-benzylglutathione", "cofactor_resource_id": "DB03602", "neighbor_flag": "Y", "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "KXGVEGMKQFWNSR-LLQZFEROSA-N", "cofactor_smiles": "[H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)[C@@H](O)C[C@@]1([H])[C@@]2([H])CC[C@]2([H])C[C@H](O)CC[C@]12C", "cofactor_chem_comp_id": "DXC", "cofactor_name": "Deoxycholic acid", "cofactor_resource_id": "DB03619", "mechanism_of_action": "As a bile acid, deoxycholic acid emulsifies fat in the gut. Synthetically derived deoxycholic acid, when injected, stimulates a targeted breakdown of adipose cells by disrupting the cell membrane and causing adipocytolysis. This results in an inflammatory reaction and clearing of the adipose tissue remnants by macrophages. Deoxycholic acid's actions are reduced by albumin and tissue-associated proteins, therefore its effect is limited to protein-poor subcutaneous fat tissue. Protein-rich tissues like muscle and skin are unaffected by deoxycholic acid, contributing to its safety profile. ", "neighbor_flag": "N", "pubmed_ids": [11511179], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "HXJDWCWJDCOHDG-RYUDHWBXSA-N", "cofactor_smiles": "CCCCCCSC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O", "cofactor_chem_comp_id": "LEE", "cofactor_name": "S-Hexylglutathione", "cofactor_resource_id": "DB04132", "neighbor_flag": "N", "pubmed_ids": [20606271, 10592235], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "VFLDPWHFBUODDF-FCXRPNKRSA-N", "cofactor_smiles": "COC1=CC(\\C=C\\C(=O)CC(=O)\\C=C\\C2=CC(OC)=C(O)C=C2)=CC=C1O", "cofactor_chem_comp_id": "CC9", "cofactor_name": "Curcumin", "cofactor_resource_id": "DB11672", "mechanism_of_action": "Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage [F114]. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2 [F114].", "neighbor_flag": "N", "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "BTXNYTINYBABQR-UHFFFAOYSA-N", "cofactor_smiles": "CC1=C2C3=C(C)C=C(O)C4=C3C3=C5C2=C(C(O)=C1)C(=O)C1=C5C(=C(O)C=C1O)C1=C(O)C=C(O)C(C4=O)=C31", "cofactor_name": "Hypericin", "cofactor_resource_id": "DB13014", "neighbor_flag": "N", "pubmed_ids": [15461448], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"cofactor_in_ch_ikey": "CBRJPFGIXUFMTM-WDEREUQCSA-N", "cofactor_smiles": "C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2", "cofactor_name": "Ritlecitinib", "cofactor_resource_id": "DB14924", "mechanism_of_action": "Alopecia areata is an autoimmune disorder that causes hair loss mainly in the scalp but also on the face and other areas. In normal conditions, hair follicles are immune-privileged sites characterized by the presence of well-suppressed natural killer cells. However, disruptions to this system can lead to the loss of immune privilege and cause alopecia areata. Genome-wide association studies have linked the overexpression of UL16-binding protein 3 (ULBP3), a protein that binds to natural killer cell receptors, to the pathogenesis of alopecia areata. The overexpression of ULBP3 promotes the attack of cytotoxic cluster of differentiation 8-positive (CD8+) NK group 2D-positive (NKG2D+) T cells to hair follicles, leading to hair follicle dystrophy. CD8+ NKG2D+ T cells promote the inflammation of hair follicles through interferon-\u03b3 (IFN-\u03b3) and interleukin-15 (IL-15) signaling pathways, which consequently activate Janus kinase (JAK)/signal transducer and activator of transcription (STAT) molecular pathways. Therefore, JAK inhibitors have been proposed for the treatment of alopecia areata.[A260147,A260152] \r\n\r\nRitlecitinib inhibits Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family in an irreversible manner by blocking the adenosine triphosphate (ATP) binding site. _In vitro_, ritlecitinib inhibits cytokine-induced STAT phosphorylation mediated by JAK3-dependent receptors and the signaling of immune receptors dependent on TEC kinase family members.[L47092] Although it is possible that JAK inhibitors, such as ritlecitinib, inhibit the inflammatory pathways activated in alopecia areata, the precise mechanism of action has not been fully elucidated.[A260147,L47092]", "neighbor_flag": "N", "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "P08263"}, {"binding_assay_value": 7.86, "binding_assay_value_type": "pIC50", "cofactor_smiles": "C=C(C)C(=O)c1ccc(OCC(=O)NCCC(=O)NCc2cc(CNC(=O)CCNC(=O)COc3ccc(C(=O)C(=C)CC)c(Cl)c3Cl)cc(C(N)=O)c2)c(Cl)c1Cl", "cofactor_resource_id": "CHEMBL211727", "neighbor_flag": "N", "pubmed_ids": [16675217], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "17526"}, {"binding_assay_value": 6.75, "binding_assay_value_type": "pIC50", "cofactor_smiles": "CC(=O)N/N=C(/c1ccccc1O)c1cc(Br)ccc1O", "cofactor_resource_id": "CHEMBL3310889", "neighbor_flag": "N", "pubmed_ids": [25002233], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "17526"}, {"binding_assay_value": 6.62, "binding_assay_value_type": "pIC50", "cofactor_smiles": "O=C(c1ccccc1O)c1cc(Br)ccc1O", "cofactor_resource_id": "CHEMBL3310888", "neighbor_flag": "N", "pubmed_ids": [25002233], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "17526"}, {"binding_assay_value": 6.48, "binding_assay_value_type": "pIC50", "cofactor_smiles": "O=C(NN=C(c1ccccc1O)c1ccccc1O)c1ccccc1", "cofactor_resource_id": "CHEMBL3310887", "neighbor_flag": "N", "pubmed_ids": [25002233], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "17526"}, {"binding_assay_value": 6.08, "binding_assay_value_type": "pKi", "cofactor_smiles": "CCCCCCSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O", "cofactor_resource_id": "CHEMBL58135", "neighbor_flag": "N", "pubmed_ids": [8289195], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "17526"}], "rcsb_id": "1PKW_1"}